Does FDA’s UPLIZNA gMG Expansion Reshape the Bull Case for Amgen’s Diversification …

Earlier this month, the Muscular Dystrophy Association highlighted the U.S. FDA’s approval of Amgen’s UPLIZNA (inebilizumab-cdon) for adults with …